Suppr超能文献

根治性放化疗后胆道癌切除术后失败模式及胆道干预需求。

Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation.

机构信息

Harvard Medical School, Boston, MA, USA.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Ann Surg Oncol. 2020 Dec;27(13):5161-5172. doi: 10.1245/s10434-020-08967-9. Epub 2020 Aug 1.

Abstract

BACKGROUND

This study assessed patterns of failure and rates of subsequent biliary intervention among patients with resected biliary tract cancers (BTCs) including gallbladder carcinoma (GBC) and extra- and intrahepatic cholangiocarcinoma (eCCA and iCCA) treated with adjuvant chemoradiation therapy (CRT).

METHODS

In this single-institution retrospective analysis of 80 patients who had GBC (n = 29), eCCA (n = 43), or iCCA (n = 8) treated with curative-intent resection and adjuvant CRT from 2007 to 2017, the median radiation dose was 50.4 Gy (range 36-65 Gy) with concurrent 5-fluorouracil (5-FU) chemotherapy. All but two of the patients received adjuvant chemotherapy. The 2-year locoregional failure (LRF), 2-year recurrence-free survival (RFS), and 2-year overall survival (OS), and univariate predictors of LRF, RFS, and OS were calculated for the entire cohort and for a subgroup excluding patients with iCCA (n = 72). The predictors of biliary interventions also were assessed.

RESULTS

Of the 80 patients (median follow-up period, 30.5 months; median OS, 33.9 months), 54.4% had American Joint Committee on Cancer (AJCC) stage 1 or 2 disease, 57.1% were lymph node-positive, and 66.3% underwent margin-negative resection. For the entire cohort, 2-year LRF was 23.8%, 2-year RFS was  43.7%, and 2-year OS was 62.1%.  When patients with iCCA were excluded, the 2-year LRF was 22.6%, the 2-year RFS was 43.9%, and the 2-year OS was 59.2%. In the overall and subgroup univariate analyses, lymph node positivity was associated with greater LRF, whereas resection margin was not. Biliary intervention was required for 12 (63.2%) of the 19 patients with LRF versus 11 (18%) of the 61 patients without LRF (P < 0.001). Of the 12 patients with LRF who required biliary intervention, 4 died of biliary complications.

CONCLUSIONS

The LRF rates remained significant despite adjuvant CRT. Lymph node positivity may be associated with increased risk of LRF. Positive margins were not associated with greater LRF, suggesting that CRT may mitigate LRF risk for this group. An association between LRF and higher rates of subsequent biliary interventions was observed, which may yield significant morbidity. Novel strategies to decrease the rates of LRF should be considered.

摘要

背景

本研究评估了接受辅助放化疗(CRT)治疗的胆道癌(BTC)患者(包括胆囊癌[GBC]和肝外及肝内胆管癌[eCCA 和 iCCA])的失败模式和随后胆道介入治疗的发生率。

方法

在这项对 80 名患者的单机构回顾性分析中,这些患者在 2007 年至 2017 年间接受了根治性切除术和辅助 CRT 治疗,其中 GBC(n=29)、eCCA(n=43)或 iCCA(n=8),中位放射剂量为 50.4Gy(范围 36-65Gy),同时接受 5-氟尿嘧啶(5-FU)化疗。除了两名患者外,所有患者均接受了辅助化疗。计算了整个队列和排除 iCCA 患者(n=72)的亚组的 2 年局部区域复发率(LRF)、2 年无复发生存率(RFS)和 2 年总生存率(OS),以及 LRF、RFS 和 OS 的单变量预测因素。还评估了胆道干预的预测因素。

结果

在 80 名患者(中位随访时间为 30.5 个月;中位 OS 为 33.9 个月)中,54.4%的患者为美国癌症联合委员会(AJCC)第 1 或 2 期疾病,57.1%的患者淋巴结阳性,66.3%的患者接受了切缘阴性的切除术。对于整个队列,2 年 LRF 为 23.8%,2 年 RFS 为 43.7%,2 年 OS 为 62.1%。当排除 iCCA 患者时,2 年 LRF 为 22.6%,2 年 RFS 为 43.9%,2 年 OS 为 59.2%。在整体和亚组的单变量分析中,淋巴结阳性与较高的 LRF 相关,而切缘则无。19 例 LRF 患者中有 12 例(63.2%)需要胆道介入治疗,61 例无 LRF 患者中有 11 例(18%)需要胆道介入治疗(P<0.001)。在 12 例需要胆道介入治疗的 LRF 患者中,4 例死于胆道并发症。

结论

尽管接受了辅助 CRT,但 LRF 率仍然显著。淋巴结阳性可能与 LRF 风险增加有关。切缘阳性与较高的 LRF 无关,这表明 CRT 可能降低了这组患者的 LRF 风险。LRF 与随后胆道介入治疗率较高之间存在关联,这可能会导致显著的发病率。应考虑采用降低 LRF 发生率的新策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验